DE602007009358D1 - Verfahren zur behandlung einer akuten gefässerkrankung - Google Patents

Verfahren zur behandlung einer akuten gefässerkrankung

Info

Publication number
DE602007009358D1
DE602007009358D1 DE602007009358T DE602007009358T DE602007009358D1 DE 602007009358 D1 DE602007009358 D1 DE 602007009358D1 DE 602007009358 T DE602007009358 T DE 602007009358T DE 602007009358 T DE602007009358 T DE 602007009358T DE 602007009358 D1 DE602007009358 D1 DE 602007009358D1
Authority
DE
Germany
Prior art keywords
mammal
acute vascular
vascular disease
treating acute
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007009358T
Other languages
English (en)
Inventor
Herman Jan Thijmen Coelingh Bennink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantarhei Bioscience BV
Original Assignee
Pantarhei Bioscience BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience BV filed Critical Pantarhei Bioscience BV
Priority claimed from PCT/NL2007/050006 external-priority patent/WO2007081206A1/en
Publication of DE602007009358D1 publication Critical patent/DE602007009358D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE602007009358T 2006-01-09 2007-01-09 Verfahren zur behandlung einer akuten gefässerkrankung Active DE602007009358D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75702706P 2006-01-09 2006-01-09
EP06100159 2006-01-09
PCT/NL2007/050006 WO2007081206A1 (en) 2006-01-09 2007-01-09 A method of treating an acute vascular disorder

Publications (1)

Publication Number Publication Date
DE602007009358D1 true DE602007009358D1 (de) 2010-11-04

Family

ID=36100928

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007009358T Active DE602007009358D1 (de) 2006-01-09 2007-01-09 Verfahren zur behandlung einer akuten gefässerkrankung

Country Status (4)

Country Link
CN (1) CN101378762A (de)
AT (1) ATE481973T1 (de)
DE (1) DE602007009358D1 (de)
ES (1) ES2352547T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TN2017000497A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
MX2017016276A (es) * 2015-06-18 2018-06-19 Mithra Pharmaceuticals S A Unidad de dosificacion orodispersable que contiene un componente estetrol.
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途

Also Published As

Publication number Publication date
ES2352547T3 (es) 2011-02-21
CN101378762A (zh) 2009-03-04
ATE481973T1 (de) 2010-10-15

Similar Documents

Publication Publication Date Title
ATE534377T1 (de) Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen
ATE340580T1 (de) Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
DE602008001783D1 (de) Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
DK1446128T3 (da) Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
TW200740773A (en) Diaminopyrimidines as P2X3 and P2X2/3 modulators
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
TN2009000012A1 (en) Amino-piperidine derivatives as cetp inhibitors
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
ATE536349T1 (de) In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
PL2170346T3 (pl) Leczenie lub profilaktyka zaburzeń związanych z nadciśnieniem w okresie ciąży lub opóźnienie wzrostu płodu
BRPI0712101B8 (pt) ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo
ECSP099330A (es) Compuesto de indol
HRP20090078A2 (en) Novel pyridazine compound and use thereof
MX2007008555A (es) Amino-imidazolonas para la inhibicion de (-secretasa.
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
BR112012009214A2 (pt) compostos
ATE533489T1 (de) Behandlung von multiplem myelom
BRPI0511569A (pt) composições e métodos para o tratamento de distúrbio disfórico pré-menstrual
MX2009011205A (es) Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide.
CY1105883T1 (el) Μεθοδος θepαπειας ή προληψης διαταραχων οπου μεσολαβει το ανοσοποιητικο και φαρμακευτικο παρασκευασμα για χρηση σε αυτη
MX2009005795A (es) Composiciones, sintesis y metodos para usar inhibidores de colinesterasa basados en indanona.
ATE522532T1 (de) Verbindungen zur behandlung von hepatitis c
ATE551343T1 (de) Tetracyclische verbindungen zur behandlung von hepatitis c
ATE494291T1 (de) Verbindungen zur behandlung von hepatitis c